|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||2.3080 - 2.3150|
|52-week range||2.3080 - 2.3150|
|Beta (5Y monthly)||0.88|
|PE ratio (TTM)||N/A|
|Earnings date||07 Jun 2023 - 12 Jun 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Enzo Biochem ( NYSE:ENZ ) Second Quarter 2023 Results Key Financial Results Revenue: US$16.3m (down 52% from 2Q 2022...
Key Insights Institutions' substantial holdings in Enzo Biochem implies that they have significant influence over the...
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...